InfuSystem Set To Be A Cash Cow In 2026 [Seeking Alpha]
Astrana Health Inc. (ASTH)
Company Research
Source: Seeking Alpha
INFU's integration of Apollo Medical's billing system and new ERP is expected to drive significant operational efficiencies and margin gains in FY2026. Capital discipline enables INFU to repurchase shares and reduce debt, while growth opportunities in Wound Care and Oncology remain robust. With multiple tailwinds—including likely Russell 2000 inclusion and ongoing buybacks—INFU is positioned to outperform the market over the next two years. Phynart Studio/E+ via Getty Images In my August 2025 article on InfuSystem ( INFU ), I noted with respect to the recent CEO change that “there is a new sheriff in town.” New CEO Carrie Lachance clearly articulated on the Q2'25 This article was written by Analyst's Disclosure: I/we have a beneficial long position in the shares of INFU either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have
Show less
Read more
Impact Snapshot
Event Time:
ASTH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ASTH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ASTH alerts
High impacting Astrana Health Inc. news events
Weekly update
A roundup of the hottest topics
ASTH
News
- Astrana Health (NASDAQ:ASTH) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..MarketBeat
- Astrana Health (NASDAQ:ASTH) was given a new $37.00 price target on by analysts at Jefferies Financial Group Inc..MarketBeat
- Astrana Health (NASDAQ:ASTH) was given a new $26.00 price target on by analysts at Barclays PLC.MarketBeat
- A Look at Astrana Health's (ASTH) Valuation Following Earnings Miss and Lowered Guidance [Yahoo! Finance]Yahoo! Finance
- Astrana Health (NASDAQ:ASTH) was downgraded by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a> from a "hold (c-)" rating to a "sell (d+)" rating.MarketBeat